Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib works better than methotrexate for severe alopecia areata.

Letrozole may help prevent seizures by reducing certain hormone levels.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alefacept does not effectively treat severe alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

ALRN-6924 may prevent hair loss caused by chemotherapy.